Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Intas Pharma ropes in Sujit Mandal as Associate Vice President - Manufacturing Finance

Ruchika Sharma10 Nov 2025 2:30 PM IST

Ahmedabad: Intas Pharma has announced the appointment of Sujit Mandal as Associate Vice President – Manufacturing Finance.Sujit brings rich...

USFDA concludes inspection at Marksans Pharma Goa facility with zero Form 483 observation

Ruchika Sharma10 Nov 2025 12:34 PM IST

Mumbai: Marksans Pharma has announced that the U.S. Food and Drug Administration (USFDA) has concluded an inspection at the 2nd manufacturing facility...

Merck inks pact with Dr Falk Pharma for certain development, commercialization rights to MK 8690

Ruchika Sharma10 Nov 2025 11:15 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the company, through a subsidiary Prometheus BioSciences, has...

Biocon expects 50 percent drop in costs for developing complex biosimilars: Top executive

Biocon gets 2 USFDA observations for Visakhapatnam facility

Ruchika Sharma9 Nov 2025 5:00 PM IST

Biocon has announced that the U.S. Food and Drug Administration (US FDA) has concluded an inspection with two observations at its API facility...

Mankind Pharma net profit declines 21 percent to Rs 520 crore in Q2

Ruchika Sharma9 Nov 2025 4:00 PM IST

Mankind Pharma Ltd has posted a 21 percent year-on-year decline in its consolidated profit after tax (PAT) to Rs 520 crore for the quarter ended...

JnJ bags USFDA approval for Caplyta for major depressive disorder

Ruchika Sharma9 Nov 2025 1:30 PM IST

Titusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved CAPLYTA (lumateperone) as an...

Merck enters into RnD funding agreement with Blackstone Life Sciences for Sacituzumab Tirumotecan

Ruchika Sharma9 Nov 2025 12:45 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that the company has entered into an agreement to receive...

Boehringer Ingelheim, CDR-Life enter into new agreement to develop autoimmune disease molecule

Ruchika Sharma9 Nov 2025 11:30 AM IST

Ingelheim: Boehringer Ingelheim and CDR-Life, Inc. have announced a new global licensing agreement to develop CDR-Life’s unique antibody based ...

Ghaziabad: More than 15.7 lakh vials of banned cough syrup seized, 8 arrested

Ruchika Sharma8 Nov 2025 5:47 PM IST

Ghaziabad: Following the recent deaths of infants in Madhya Pradesh linked to toxic cough syrup, authorities across the country have stepped up...

Torrent Pharma net profit rises 30 percent to Rs 591 crore in Q2

Ruchika Sharma8 Nov 2025 4:30 PM IST

Torrent Pharmaceuticals has posted a robust 30 percent jump in its consolidated profit after tax (PAT) at Rs 591 crore for the September quarter,...

Lupin Bioresearch Center gets zero USFDA observation after successful inspection, assessment

Ruchika Sharma8 Nov 2025 3:08 PM IST

Mumbai: Lupin Limited, a Global pharma major, has announced that the United States Food and Drug Administration (U.S. FDA) has...

JnJ Darzalex faspro approved by USFDA for high risk smoldering multiple myeloma

Ruchika Sharma8 Nov 2025 12:36 PM IST

Horsham: Johnson & Johnson has announced the U.S. Food and Drug Administration (FDA) has approved DARZALEX FASPRO (daratumumab and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok